Quantitative and Qualitative Distinctions between HIV-1 and SIV Reservoirs: Implications for HIV-1 Cure-Related Studies
Viruses · 2024
DOI: 10.3390/v16040514 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Viruses, 2024. Verfasst von Joseph C Mudd. Beteiligte Einrichtung: Tulane National Primate Research Center, Covington, LA 70433, USA. Hauptthemen laut MEDLINE: HIV Infections, HIV-1, Simian Acquired Immunodeficiency Syndrome, Simian Immunodeficiency Virus. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 141 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIAID NIH HHS, NIAID/NIH.
Abstract (Originalsprache)
The persistence of the latent viral reservoir is the main hurdle to curing HIV-1 infection. SIV infection of non-human primates (NHPs), namely Indian-origin rhesus macaques, is the most relevant and widely used animal model to evaluate therapies that seek to eradicate HIV-1. The utility of a model ultimately rests on how accurately it can recapitulate human disease, and while reservoirs in the NHP model behave quantitatively very similar to those of long-term suppressed persons with HIV-1 (PWH) in the most salient aspects, recent studies have uncovered key nuances at the clonotypic level that differentiate the two in qualitative terms. In this review, we will highlight differences relating to proviral intactness, clonotypic structure, and decay rate during ART between HIV-1 and SIV reservoirs and discuss the relevance of these distinctions in the interpretation of HIV-1 cure strategies. While these, to some degree, may reflect a unique biology of the virus or host, distinctions among the proviral landscape in SIV are likely to be shaped significantly by the condensed timeframe of NHP studies. ART is generally initiated earlier in the disease course, and animals are virologically suppressed for shorter periods before receiving interventions. Because these are experimental variables dictated by the investigator, we offer guidance on study design for cure-related studies performed in the NHP model. Finally, we highlight the case of GS-9620 (Vesatolimod), an antiviral TLR7 agonist tested in multiple independent pre-clinical studies in which virological outcomes may have been influenced by study-related variables.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Tulane National Primate Research Center, Covington, LA 70433, USA.
- Department of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Förderung
- NIH HHS
- NIAID NIH HHS
- NIAID/NIH
- National Institute of Allergy and Infectious Disease (NIAID/NIH)
Zitieren
APA
Mudd, J. C. (2024). Quantitative and Qualitative Distinctions between HIV-1 and SIV Reservoirs: Implications for HIV-1 Cure-Related Studies. Viruses. https://doi.org/10.3390/v16040514
Vancouver
Mudd JC. Quantitative and Qualitative Distinctions between HIV-1 and SIV Reservoirs: Implications for HIV-1 Cure-Related Studies. Viruses. 2024. doi:10.3390/v16040514
BibTeX
@article{Mudd2024,
author = {Mudd, Joseph C},
title = {Quantitative and Qualitative Distinctions between HIV-1 and SIV Reservoirs: Implications for HIV-1 Cure-Related Studies},
journal = {Viruses},
year = {2024},
doi = {10.3390/v16040514}
}
EUVIMED